<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    ANI Pharmaceuticals, Inc.

    ANI Pharmaceuticals, Inc.

    An emerging leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals ...

    An emerging leader in the specialty pharmaceuti...

    Filing Type:    PU
    Nutripy, Inc.

    Nutripy, Inc.

    Life gets in the way of eating right. With a quick assessment of your lifestyle, N...

    Life gets in the way of eating right. With a qu...

    Fundraising Status:    EC
    Filing Type:    CF
    Fonar Corporation

    Fonar Corporation

    Fonar Corporation, the MRI Specialist™, is the world’s leading developer and m...

    Fonar Corporation, the MRI Specialist™, is th...

    Filing Type:    PU
    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    Coloplast AS

    Coloplast AS

    Coloplast develops products and services that make life easier for people with ver...

    Coloplast develops products and services that m...

    Filing Type:    PU
    Amarantus Bioscience Holdings, Inc.

    Amarantus Bioscience Holdings, Inc.

    Amarantus BioSciences is a development-stage, publicly-traded biotechnology compan...

    Amarantus BioSciences is a development-stage, p...

    Amount Raised:    $4,300,000
    Fundraising Status:    VT
    Filing Type:    PR
    Replimune Group, Inc.

    Replimune Group, Inc.

    Cancer is one of the most difficult diseases to treat. It is constantly changing, ...

    Cancer is one of the most difficult diseases to...

    Filing Type:    PU
    Atreca, Inc.

    Atreca, Inc.

    Atreca is a biotechnology company developing novel therapeutics drawn from human i...

    Atreca is a biotechnology company developing no...

    Filing Type:    PU
    INmune Bio Inc.

    INmune Bio Inc.

    INmune Bio Inc. is a clinical stage biotechnology company that is developing new i...

    INmune Bio Inc. is a clinical stage biotechnolo...

    Filing Type:    PU
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    Moleculin Biotech, Inc.

    Moleculin Biotech, Inc.

    Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the ...

    Moleculin Biotech, Inc. is a clinical stage pha...

    Filing Type:    PU
    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.